What does APOTEEK KELLES do?

APOTEEK KELLES is a pharmacy in Aalst. Private Limited, started on 2 July 1979, 2 establishments.

What is the address of APOTEEK KELLES?

The registered office of APOTEEK KELLES is located at Moorsel-Dorp 21, 9310 Aalst.

Is APOTEEK KELLES still active?

Yes. According to the CBE (30 October 2026) APOTEEK KELLES is active, legal situation “Normale toestand”, started on 2 July 1979.

Is APOTEEK KELLES registered on Peppol?

Yes, APOTEEK KELLES is registered on the Peppol network with ID 0208:0419591613.

What is the enterprise number of APOTEEK KELLES?

The enterprise number of APOTEEK KELLES is BE0419591613.

When was APOTEEK KELLES founded?

APOTEEK KELLES was founded on 2 July 1979.

Who are the directors of APOTEEK KELLES?

According to the 2025 annual accounts, the directors of APOTEEK KELLES are: ARNAUD BERKEN, AN MARIN.

Is APOTEEK KELLES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 July 1979; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did APOTEEK KELLES make in 2025?

APOTEEK KELLES posted a profit after taxes of € 59,302 in financial year 2025.

What is the revenue of APOTEEK KELLES?

As a small company, APOTEEK KELLES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 486,585.

How much does an employee at APOTEEK KELLES earn?

The average wage cost per full-time employee at APOTEEK KELLES was € 57,200 in 2025: staff costs of € 314,359 for 5.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTEEK KELLES have?

According to the 2025 annual accounts, APOTEEK KELLES has 5.5 full-time equivalents (FTE).

Does APOTEEK KELLES have a website?

Yes, APOTEEK KELLES has a website at apotheekkelles.be.

APOTEEK KELLES (Private Limited) - Aalst - BE0419591613

Dossier APOTEEK KELLES, printed on 30 October 2026 from databakkes.be/en/0419591613/apoteek-kelles. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTEEK KELLES from Aalst, company number BE0419591613, closed financial year 2025 with a result of € 59,302 after tax. For that financial year APOTEEK KELLES recorded a gross margin of € 486,585 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 81,460 to € 59,302. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Growing

€ 1.2 million

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 59,302

▼ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 335,512

▲ 52% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.2 million.

People and assets in 2025

Full-time equivalents

5.5

▲ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 314,359

▼ 2% vs 2024

€ 57,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 48,636

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 114,104

▼ 33% vs 2024

€ 56,180 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 332,245

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 57,050

▼ 23% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 500,583 Gross margin 2022: € 500,583 First fiscal year in the series	€ 510,448 Gross margin 2023: € 510,448 ▲ 2% vs 2022 (€ 500,583) Favourable step	€ 524,409 Gross margin 2024: € 524,409 ▲ 3% vs 2023 (€ 510,448) Favourable step	€ 486,585 Gross margin 2025: € 486,585 ▼ 7% vs 2024 (€ 524,409) Unfavourable step	▼ 7%
Profit after taxes	€ 83,256 Profit after taxes 2022: € 83,256 First fiscal year in the series	€ 79,409 Profit after taxes 2023: € 79,409 ▼ 5% vs 2022 (€ 83,256) Unfavourable step	€ 81,460 Profit after taxes 2024: € 81,460 ▲ 3% vs 2023 (€ 79,409) Favourable step	€ 59,302 Profit after taxes 2025: € 59,302 ▼ 27% vs 2024 (€ 81,460) Unfavourable step	▼ 27%
Equity	€ 993,291 Equity 2022: € 993,291 First fiscal year in the series	€ 1,072,700 Equity 2023: € 1,072,700 ▲ 8% vs 2022 (€ 993,291) Favourable step	€ 1,154,159 Equity 2024: € 1,154,159 ▲ 8% vs 2023 (€ 1,072,700) Favourable step	€ 1,213,461 Equity 2025: € 1,213,461 ▲ 5% vs 2024 (€ 1,154,159) Favourable step	▲ 5%
Total debts	€ 390,595 Total debts 2022: € 390,595 First fiscal year in the series	€ 303,286 Total debts 2023: € 303,286 ▼ 22% vs 2022 (€ 390,595) Favourable step	€ 247,923 Total debts 2024: € 247,923 ▼ 18% vs 2023 (€ 303,286) Favourable step	€ 507,145 Total debts 2025: € 507,145 ▲ 105% vs 2024 (€ 247,923) Unfavourable step	▲ 105%
Cash	€ 270,886 Cash 2022: € 270,886 First fiscal year in the series	€ 228,118 Cash 2023: € 228,118 ▼ 16% vs 2022 (€ 270,886) Unfavourable step	€ 220,758 Cash 2024: € 220,758 ▼ 3% vs 2023 (€ 228,118) Unfavourable step	€ 335,512 Cash 2025: € 335,512 ▲ 52% vs 2024 (€ 220,758) Favourable step	▲ 52%
Land & buildings	€ 5,083 Land & buildings 2022: € 5,083 First fiscal year in the series	€ 2,661 Land & buildings 2023: € 2,661 ▼ 48% vs 2022 (€ 5,083) Unchanged	€ 2,484 Land & buildings 2024: € 2,484 ▼ 7% vs 2023 (€ 2,661) Unchanged	-
Retained profit	€ 974,691 Retained profit 2022: € 974,691 First fiscal year in the series	€ 1,054,100 Retained profit 2023: € 1,054,100 ▲ 8% vs 2022 (€ 974,691) Favourable step	€ 1,135,559 Retained profit 2024: € 1,135,559 ▲ 8% vs 2023 (€ 1,054,100) Favourable step	€ 1,194,861 Retained profit 2025: € 1,194,861 ▲ 5% vs 2024 (€ 1,135,559) Favourable step	▲ 5%
Bank debt	€ 284,320 Bank debt 2022: € 284,320 First fiscal year in the series	€ 232,994 Bank debt 2023: € 232,994 ▼ 18% vs 2022 (€ 284,320) Favourable step	€ 170,524 Bank debt 2024: € 170,524 ▼ 27% vs 2023 (€ 232,994) Favourable step	€ 114,104 Bank debt 2025: € 114,104 ▼ 33% vs 2024 (€ 170,524) Favourable step	▼ 33%
Balance sheet total	€ 1,383,885 Balance sheet total 2022: € 1,383,885 First fiscal year in the series	€ 1,375,985 Balance sheet total 2023: € 1,375,985 ▼ 1% vs 2022 (€ 1,383,885) Unchanged	€ 1,402,082 Balance sheet total 2024: € 1,402,082 ▲ 2% vs 2023 (€ 1,375,985) Unchanged	€ 1,720,606 Balance sheet total 2025: € 1,720,606 ▲ 23% vs 2024 (€ 1,402,082) Unchanged	▲ 23%
Employees (FTE)	4.8 Employees (FTE) 2022: 4.8 First fiscal year in the series	4.6 Employees (FTE) 2023: 4.6 ▼ 0.2 vs 2022 (4.8) Unchanged	4.7 Employees (FTE) 2024: 4.7 ▲ 0.1 vs 2023 (4.6) Unchanged	5.5 Employees (FTE) 2025: 5.5 ▲ 0.8 vs 2024 (4.7) Unchanged	▲ 0.8

Key figures of APOTEEK KELLES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTEEK KELLES?

What happened at APOTEEK KELLES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: profit of € 59,302 (▼ 27% vs 2024). filed late Source: NBB ↗
Mar 1, 2018 New establishment in Lebbeke. KBO
Jul 2, 1979 New establishment in Aalst. KBO
Jul 2, 1979 Start of the company according to the CBE. KBO

In short

From € 83,256 profit in 2022 to € 59,302 profit in 2025.

Paid € 129,440 in corporate taxes since 2022.

Best year ever: 2022, with € 83,256 profit.

On average € 88,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

PHARM@21 100%

The stake of PHARM@21 comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTEEK KELLES

Behind APOTEEK KELLES are ARNAUD BERKEN and AN MARIN. The shares are held by PHARM@21 (100%).

Directors

According to the 2025 annual accounts

ARNAUD BERKEN

Director

AN MARIN

Director

Shareholders

PHARM@21

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Moorsel-Dorp 21

9310 Aalst

2.273.422.652

Kapellenstraat 57

9280 Lebbeke

Active since 1 March 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekkelles.be

Technologies

AMPAlpine.jsCookie ConsentGoogle FontsNginxPlausibleVimeoYouTube EmbedreCAPTCHA

Certifications & Partners

RIZIV

Hosting & Email

Email provider

Microsoft 365

Hosting

UPCLOUD, FI

Website info

HTTPS Ja

Indexable pages 52,851

Languages NL

Features

Webshop Newsletter

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0419.591.613

VAT number

BE 0419.591.613

Registered office

Moorsel-Dorp 21, 9310 Aalst

Names & denominations

APOTEEK KELLES

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

2 July 1979

Peppol

Active · Active since 26 Feb 2026

Contact

apotheekkelles.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTEEK KELLES

Financials

What happened to APOTEEK KELLES?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Certifications & Partners

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions